Mouse

Mouse Adverse Event Insights

The FDA Center for Veterinary Medicine database holds 98 adverse event reports for Mouse, distributed across 5 distinct breeds currently tracked in the system. Of those reports, 61 involved a death outcome — producing a 6220.0% case-fatality rate among reported events, which reflects reporting severity bias rather than true population mortality. These figures are aggregated directly from openFDA's Animal & Veterinary Adverse Events endpoint and update as new voluntary submissions flow through pet owners, veterinarians, and drug manufacturers.

The most frequently reported clinical signs for Mouse are Death (48 reports), INEFFECTIVE, ANESTHESIA (16 reports), Death by euthanasia (9 reports), Dermatitis (5 reports), with Death leading the reaction traffic at 48 submissions. On the product side, Ketamine Hydrochloride is the single most-referenced drug with 33 reports, followed by Xylazine (18), Isoflurane (16), Buprenorphine (13). This combination surfaces which therapeutic classes generate the most adverse event chatter for this species — a useful starting point when comparing Mouse reporting patterns against other companion animals in the dataset.

Of the 105 Mouse reports with a coded outcome, Died accounts for the largest share at 46.7%. Annual submission volume spans 2,010 to 2,025 reports across the 16 years on file, a range that reflects evolving owner awareness, veterinary reporting habits, and new product approvals rather than stable underlying incidence. The breed-level table below breaks these patterns down further, showing how the 5 tracked mouse breeds compare on volume, deaths, and average age at report. As with all FDA adverse event data, correlation is the ceiling — causation requires clinical investigation beyond what these aggregates can provide.